Kiniksa Pharmaceuticals surpasses Q1 expectations, raises ARCALYST sales guidance. Click here to read an analysis of KNSA ...

TG Therapeutics reported strong revenue growth, driven by Briumvi's success in MS treatment. Find out why I upgraded my ...

FDA approves Teva and Alvotech's Selarsdi as an interchangeable biosimilar to Stelara, supporting the treatment of multiple ...

Using the latest data and perspectives, an international expert panel releases updated recommendations for optimal insulin ...

It’s common to feel nervous (and maybe even spaced out) when your doctor demonstrates how to inject yourself with ...

Subcutaneous injections of Darbe have been used to effectively treat anemia of prematurity and boost red blood cell ...

Safety profiles were comparable, with fewer treatment-related side effects in the subcutaneous group, though local injection site reactions were more common. The FDA approved subcutaneous Opdivo for ...

Vyvgart Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional. The single-dose ...

In December 2024, the Food and Drug Administration (FDA) approved the PD-1 inhibitor nivolumab (Opvido Qvantig) for use as a subcutaneous injection. Read on to learn more about this new approach ...

This article explores types of immunotherapy for upper GI cancer, how subcutaneous immunotherapy injections work, and considerations for when a doctor may add these types of therapies to a cancer ...